|
TMSB15B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.01109999764526E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.1345000039984E-08 |
| Normal-vs-Stage2 |
5.679100E-03 |
| Normal-vs-Stage3 |
1.559310E-03 |
| Normal-vs-Stage4 |
5.648000E-04 |
| Stage1-vs-Stage2 |
4.466600E-01 |
| Stage1-vs-Stage3 |
4.352000E-02 |
| Stage1-vs-Stage4 |
3.524400E-01 |
| Stage2-vs-Stage3 |
5.430200E-01 |
| Stage2-vs-Stage4 |
2.019800E-01 |
| Stage3-vs-Stage4 |
6.350300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.52250000051701E-07 |
| Normal-vs-AfricanAmerican |
4.13420000000553E-06 |
| Normal-vs-Asian |
1.817390E-03 |
| Caucasian-vs-AfricanAmerican |
1.915240E-01 |
| Caucasian-vs-Asian |
4.879800E-01 |
| AfricanAmerican-vs-Asian |
8.348800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.73800000344582E-08 |
| Normal-vs-Female |
1.7883800000007E-05 |
| Male-vs-Female |
4.745400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.210610E-04 |
| Normal-vs-Age(41-60Yrs) |
2.50950000002526E-07 |
| Normal-vs-Age(61-80Yrs) |
1.83240999999112E-05 |
| Normal-vs-Age(81-100Yrs) |
1.092170E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.676180E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.851600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.740300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.075400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.279600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.684800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.025800E-04 |
| Normal-vs-Grade 2 |
7.87299999638336E-08 |
| Normal-vs-Grade 3 |
4.46320000000444E-05 |
| Normal-vs-Grade 4 |
3.340900E-03 |
| Grade 1-vs-Grade 2 |
4.550200E-01 |
| Grade 1-vs-Grade 3 |
2.575600E-01 |
| Grade 1-vs-Grade 4 |
8.327600E-01 |
| Grade 2-vs-Grade 3 |
2.323000E-01 |
| Grade 2-vs-Grade 4 |
5.389800E-01 |
| Grade 3-vs-Grade 4 |
2.661000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.580900E-04 |
| Normal-vs-ccB subtype |
1.84569999950313E-07 |
| ccA subtype-vs-ccB subtype |
1.806050E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.65960000034715E-07 |
| Normal-vs-N1 |
4.196200E-02 |
| N0-vs-N1 |
7.489400E-01 |
|
|
